Definitive Healthcare Corp. released its first-quarter fiscal 2026 results, reporting total revenue of $55.9 million, a 6% decline from $59.2 million in the prior-year period.2827
Financial Highlights
The company posted an adjusted EBITDA of $15.3 million, equating to a 27% margin, surpassing the high end of guidance by $2.3 million. Adjusted net income reached $8.5 million, up from $7.0 million year-over-year. Cash flow from operations stood at $11.6 million, while unlevered free cash flow hit $18.0 million for the quarter. Trailing 12-month unlevered free cash flow approximated $50 million.2728
A significant net loss of $192.4 million, or 344% of revenue, stemmed primarily from $197.2 million in goodwill impairment charges.
CEO Kevin Coop’s Key Remarks
CEO Kevin Coop highlighted the results as a solid start to the year, positioning the company to meet or exceed full-year targets. “Total revenue was $55.9 million, down 6% year-over-year. The Adjusted EBITDA was $15.3 million, representing a margin of 27%, which was $2.3 million above the high end of our guidance,” Coop stated.28
Coop attributed outperformance to expense discipline and strategic investments aimed at resuming top-line growth. He noted modest growth in the diversified and provider businesses, which comprise over 60% of revenue, while life sciences faced headwinds from claims disruptions and macroeconomic pressures.
Positive indicators included an improved year-over-year net dollar retention rate and the highest win-back quarter in over three years. “Several six-figure win backs in diversified and med tech highlight common themes we see emerging,” Coop added, pointing to superior data quality over competitors.28
Strategic Priorities Update
Coop reviewed progress across four pillars: data differentiation, integrations, customer success, and innovation. Recent enhancements to claims data received strong feedback, and AI investments aim to boost data collection velocity.
Nearly 50 new integrations were completed in the quarter, reducing integration time by 50% year-over-year. New offerings include HubSpot and enhanced Salesforce integrations to embed company data into customers’ workflows.
Customer success efforts yielded upsell wins, such as with a biopharma client post-acquisition.
2026 Outlook
For Q2 2026, Definitive Healthcare expects revenue of $55.0-$56.0 million, adjusted EBITDA of $13.5-$14.5 million (24%-26% margin), and adjusted net income of $5.0-$6.0 million ($0.03-$0.04 per share).
Full-year guidance projects revenue of $220.0-$226.0 million, adjusted EBITDA of $55.0-$59.0 million (25%-26% margin), and adjusted net income of $23.0-$27.0 million ($0.16-$0.19 per share).27
